Patient guide · Reviewed June 2026
GLP-1 Medications, Pregnancy, Fertility and Breastfeeding — What Australian Guidance Says
If you're taking a GLP-1 medication and thinking about pregnancy, currently pregnant, or breastfeeding — here's what the evidence actually says, sourced from peer-reviewed Australian and international research.
Published 2026-06-01 · Clinically reviewed 2026-06-03
Patient guide · Reviewed June 2026
Why GLP-1 medications and pregnancy don't mix
The TGA classifies semaglutide as a pregnancy category D medication, and Australia's Best Use of Medicines in Pregnancy database states that GLP-1 receptor…
The TGA classifies semaglutide as a pregnancy category D medication, and Australia's Best Use of Medicines in Pregnancy database states that GLP-1 receptor agonists should not be used in pregnancy, citing inadequate human safety information regarding fetal risk. This caution reflects an absence of sufficient evidence to rule out harm, not proof that harm occurs.
How long before conception should you stop?
A 2025 systematic review published in *Annals of Medicine and Surgery* sets out the pharmacological basis: the recommended washout period is based on each drug's half-life, timed to allow at least five half-lives to clear before conception.
- Semaglutide (Ozempic, Wegovy) — half-life ~7 days, requiring discontinuation at least 35 days before conception
- Tirzepatide (Mounjaro) — half-life ~5 days, requiring 25–35 days before conception
- Liraglutide (Saxenda, Victoza) — half-life ~13 hours, requiring only around 3 days before conception
In practice, Australian clinical guidance often rounds up for extra safety margin: peer-reviewed research notes current guidelines recommend cessation of semaglutide at least eight weeks prior to conception, and many providers default to this more conservative two-month window across the longer-acting medications.
Patient guide · Reviewed June 2026
What if you conceive accidentally while on a GLP-1?
Real-world research examining pregnancy outcomes after first-trimester semaglutide exposure found this exposure was not associated with an increased risk of…
Real-world research examining pregnancy outcomes after first-trimester semaglutide exposure found this exposure was not associated with an increased risk of major congenital malformations compared with other diabetes treatments or with obesity alone (2.6% vs 2.3% vs 3.9% respectively). That's reassuring evidence, but the standard clinical guidance remains unchanged: if you become pregnant while on a GLP-1 medication, stop the medication and contact both your prescriber and your GP or obstetrician promptly for appropriate monitoring going forward.
Effective contraception matters while on these medications
Because of the pregnancy category D classification, effective contraception is recommended for any woman of reproductive age taking a GLP-1 receptor agonist. Worth knowing: these medications can sometimes make oral contraceptives less reliable, particularly during dose escalation or if vomiting occurs — worth raising directly with your prescriber if you rely on the pill.
Patient guide · Reviewed June 2026
The fertility upside some women don't expect
For women with PCOS or insulin resistance-driven irregular cycles, GLP-1 therapy can sometimes restore fertility as a side effect of improved insulin…
For women with PCOS or insulin resistance-driven irregular cycles, GLP-1 therapy can sometimes restore fertility as a side effect of improved insulin sensitivity and weight loss — meaning some women conceive sooner than planned. If fertility has historically been a challenge for you and you're starting a GLP-1, it's worth raising pregnancy planning with your doctor early.
Breastfeeding: where the guidance stands
The regulatory position here is cautious and broadly consistent across manufacturers and regulators: GLP-1 medications are generally advised against while breastfeeding, due to a lack of human safety data on excretion into breast milk.
There is one notable, more nuanced update: recent information for tirzepatide (Mounjaro) indicates it passes into breast milk in very low amounts and is not expected to be absorbed by the infant. Even so, doctors generally still advise deferring GLP-1 treatment until after weaning, rather than treating this as a green light to continue. If you need ongoing glucose management while breastfeeding, metformin and insulin remain the standard, well-established options for that purpose.
Patient guide · Reviewed June 2026
What to ask your doctor
- The exact washout period appropriate for your specific medication and dose
- Whether bridging options make sense for you during the washout window
- How your contraception plan should change during dose adjustments
- What to do if you suspect you've conceived before the washout period is complete
- If breastfeeding, what alternative options are appropriate for your situation until weaning
Find a liver elastography clinic near you
Search by suburb or postcode to see accredited clinics offering FibroScan and guided liver elastography across Australia.
Type a suburb or postcode and press Enter to search nearby.
Request a liver scan appointment
Submit your details and we'll route your request to the most appropriate elastography clinic in your area. Most clinics respond within 1–2 business days.
Take action
Request an appointment
Frequently asked questions
How long before pregnancy should I stop Ozempic or Wegovy?
At least 35 days based on half-life, though many Australian providers recommend eight weeks for semaglutide. Tirzepatide requires 25–35 days; liraglutide around three days.
Can GLP-1 medications cause birth defects?
First-trimester semaglutide exposure has not been associated with increased major malformations in available studies, but GLP-1s remain category D and should be stopped if pregnancy occurs.
Can Ozempic help me get pregnant with PCOS?
GLP-1 therapy can improve insulin sensitivity and restore ovulation in some women with PCOS — discuss contraception and pregnancy planning with your doctor before starting.
Is Mounjaro safe while breastfeeding?
GLP-1 medications are generally advised against during breastfeeding. Metformin and insulin remain standard alternatives for glucose management while nursing.
TGA Product Information (semaglutide), via Australian Best Use of Medicines in Pregnancy database; "GLP-1 receptor agonists and preconception planning," *Annals of Medicine and Surgery*, 2025; "Pregnancy outcomes following first trimester exposure to semaglutide," PMC; manufacturer product information updates, tirzepatide (Mounjaro) breastfeeding data.
This article is for educational purposes only. It does not constitute medical advice. Always consult your GP or a specialist about your individual health circumstances.
Next step
Find a liver elastography clinic near you
Search participating clinics across Australia, or talk to your GP about a baseline FIB-4 and elastography.